DCW Q2 FY27 Revenue Rises 23% as Rs 40 Crore Buyback Clears
Ask Iris
DCW Ltd reported revenue growth in the September 2026 quarter while profitability declined from a year earlier, according to the latest update dated 29 October 2026. The company also approved a Rs 40 crore share buyback alongside its Q2 FY27 results. Revenue rose to Rs 663 crore from Rs 539 crore in the corresponding quarter last year. However, EBITDA, operating margin and profit after tax were lower, pointing to pressure on earnings despite a stronger sales base. DCW manufactures and sells heavy chemical products in India. Its product portfolio includes caustic soda, soda ash, polyvinyl chloride, and specialty products such as synthetic iron oxide pigment. The quarter is important because it follows management's reduction in its FY27 steady-state EBITDA expectation. Investors will also have an opportunity to hear management's assessment of the quarter during the scheduled earnings call.
Revenue rises from the prior-year base
DCW's standalone revenue for Q2 FY27 stood at Rs 663 crore, compared with Rs 539 crore in Q2 FY26. This represents year-on-year growth of 22.9%. The reported increase came after revenue of Rs 542 crore in Q1 FY27. The September quarter therefore showed a higher revenue level than the immediately preceding quarter as well. The supplied results data does not provide a segment-wise revenue split for Q2 FY27. It also does not provide product volumes or price realisations. As a result, the reasons for the sales increase cannot be separately quantified from the available information. The revenue performance nevertheless shows that the company expanded its top line against the September 2025 comparison base.
EBITDA declines despite higher sales
EBITDA for Q2 FY27 was Rs 54.6 crore, down 12.9% year on year from Rs 62.6 crore. The decline in operating profit occurred even as revenue increased by nearly one-fourth. This gap between sales growth and EBITDA movement led to a substantial margin contraction. DCW's EBITDA margin was 8.2% in Q2 FY27, against 11.6% a year earlier. The margin narrowed by 340 basis points. The available update does not separately identify the operating cost items behind the quarterly margin movement. However, prior company commentary had pointed to pressure in PVC and CPVC margins. The Q2 numbers show that profitability did not rise in line with revenue during the quarter.
Net profit falls to Rs 10.4 crore
Profit after tax for Q2 FY27 was Rs 10.4 crore, a decline of 25.0% from the year-earlier period. DCW had reported a profit of Rs 14 crore in the September 2025 quarter, which forms the relevant comparison base. The fall in PAT was larger than the decline in EBITDA on a percentage basis. The supplied information does not provide details of finance cost, tax expense, exceptional items or other income for the quarter. Therefore, the precise drivers of the movement from EBITDA to PAT cannot be determined from the reported data. What is clear is that the company generated higher revenue but lower operating and net earnings year on year. This makes margin recovery a key point for investors assessing the Q2 print.
Q2 FY27 financial snapshot
Board approves Rs 40 crore buyback
DCW approved a Rs 40 crore buyback alongside the Q2 FY27 results, according to the update. A buyback is a corporate action through which a company repurchases its own shares, subject to the terms and regulatory disclosures issued by the company. The supplied information does not state the buyback price, the number of shares proposed to be repurchased, the record date, or the method of execution. It also does not specify the timetable for the transaction. These details will be relevant for shareholders once formally disclosed. The approval comes at a time when DCW's reported operating profitability has weakened year on year. The buyback announcement is therefore a separate capital-allocation development from the quarterly operating results.
H1 reported margin includes specified items
The update noted that H1 EBITDA included Rs 9.3 crore from a provision write-back, fair-value gains and grant amortisation, as per the cash flow statement. These items were stated to represent about 77 basis points of revenue. On the reported basis, H1 EBITDA margin was 8.0%. After adjusting for the specified items, the H1 EBITDA margin was approximately 7.2%. This distinction matters because reported EBITDA can include items that may not reflect recurring operating performance. The supplied information does not provide separate H1 revenue, EBITDA or PAT figures. It also does not indicate whether similar items affected the standalone Q2 EBITDA figure. Investors should therefore distinguish between reported H1 profitability and the adjusted margin cited in the update.
Earlier FY27 guidance was reduced
During the Q1 FY27 earnings discussion, management reduced its steady-state FY27 EBITDA expectation to around Rs 300 crore from an earlier Rs 400 crore target. The revision was attributed to contraction in PVC and CPVC margins. Management had also said that basic chemicals were expected to break even in Q2. In Q1 FY27, DCW reported revenue of Rs 542 crore, up 13.87% from Rs 476 crore in Q1 FY26. Reported Q1 net profit was Rs 35 crore, compared with Rs 11 crore a year earlier. The company had announced Rs 250 crore of capital expenditure for synthetic iron oxide pigment expansion and captive power. It had also stated a target to become net debt free by the end of FY27. These earlier disclosures provide context for the Q2 operating-margin outcome and the company's investment plans.
Earnings call scheduled for 30 October
DCW has scheduled an earnings conference call for 30 October 2026 at 2:00 PM IST to discuss its Q2 FY27 unaudited financial results. The company said management representation on the call would include Saatvik Jain, Sudarshan Ganapathy and Pradipto Mukherjee. Analysts and investors were invited to join through dial-in details and a Valorem Advisors link. The call may provide further clarity on the revenue increase, margin movement, chemical-market conditions, capital expenditure and the approved buyback. It may also address the progress towards the revised EBITDA expectation of around Rs 300 crore for FY27. No conclusion on these matters should be drawn until the company provides further disclosures. The call is the next confirmed forum for management commentary in the supplied information.
What the results mean for investors
The Q2 FY27 update presents two contrasting operating signals. DCW delivered revenue growth of 22.9%, taking quarterly revenue to Rs 663 crore. But EBITDA fell 12.9%, EBITDA margin contracted by 340 basis points, and PAT declined 25.0%. This indicates that higher revenue did not translate into stronger earnings in the reported quarter. The Rs 40 crore buyback adds a capital-allocation element to the result, although its detailed terms have not been provided in the available update. For the broader chemicals sector, the results underline the relevance of spreads and margins, particularly for businesses exposed to PVC and CPVC market conditions. The scheduled 30 October earnings call and any subsequent buyback disclosures are the confirmed next events for investors to monitor.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q2 Earnings Tracker